BioSpace News Archive

Genetown

Food Allergen Screening Method by SCIEX Receives Official Method Classification From the AOAC INTERNATIONAL

Improved mass spec method nears industrial use, promoting a possible shift in global food allergen testing

March 13, 2018
·
4 min read
Business

Goldfinch Bio Bolsters Leadership Team by Appointing Dr. Peter Mundel as Chief Scientific Officer and Electing Dr. Frank Maddux to Board of Directors

Goldfinch Bio, a company focused on precision therapies to treat patients with kidney disease, today announced the strengthening of its leadership team with the election of Franklin “Frank” W. Maddux, M.D. F.A.C.P., to its board of directors and naming Dr. Peter Mundel, M.D., chief scientific officer.

March 13, 2018
·
4 min read
Precision BioLogic Presents New Approach to Standardize and Improve Inhibitor Testing for People with Hemophilia A

New data highlights promising performance of a new kit for use in a modified Nijmegen-Bethesda Assay

March 13, 2018
·
4 min read
FDA

BioTime Submits CE Mark Application for European Approval of Renevia®

BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on addressing degenerative diseases, announced today the submission of a design dossier application for CE Mark approval to market Renevia® in Europe.

March 13, 2018
·
5 min read
Motus GI to Present at the Oppenheimer 28th Annual Healthcare Conference

- Presentation with live audio webcast to be held Tuesday, March 20 at 3:20 p.m. ET-

March 13, 2018
·
3 min read
PRN Therapeutics launches nūretin®

PRN Therapeutics, the world’s leading producer of condition-specific eye care products, today announced the launch of a novel medical food formulated to reduce the risk of and slow the progression to diabetic retinopathy.

March 13, 2018
·
2 min read
Business

Phytelligence Announces JANUS Management to Consult and Catalyze Sales Discussions in Argentina

Phytelligence brings MultiPHY™ technology to South America

March 13, 2018
·
2 min read
Business

Forbion Leads $19 Million Series B Financing of Escalier Biosciences to Advance its Topical and Systemic RORγt Therapies for Psoriasis and other Autoimmune Diseases

Advancing Escalier’s drug candidates through human proof-of-concept studies

March 13, 2018
·
3 min read
Pharm Country

The Time is Now for More Women in Science

The Leukemia & Lymphoma Society (LLS) is shining a spotlight on the women in science who are helping to lead these advances.

March 13, 2018
·
7 min read
Genetown

Sekisui Diagnostics Announces Launch of Silaris™ Influenza A&B Test

Today Sekisui Diagnostics announces the launch of the Silaris™ Influenza A&B Test. The Silaris™ test was developed by Mesa Biotech and utilizes an affordable, polymerase chain reaction (PCR) testing platform specifically for point-of-care (POC) infectious disease diagnosis.

March 13, 2018
·
3 min read